1. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression
   Qi Wu et al, 2024, Heliyon CrossRef
2. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
   Jincheng Song et al, 2021, Carcinogenesis CrossRef
3. Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control
   Xiang Zhan et al, 2020, Journal of Ethnopharmacology CrossRef
4. Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression
   Peiying Yang et al, 2019, Scientific Reports CrossRef
5. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer
   Cheng-lin Zhu et al, 2020, Digestive Diseases and Sciences CrossRef
6. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
   Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef
7. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
   Qian Zuo et al, 2024, Chinese Journal of Integrative Medicine CrossRef
8. The Development of Toad Toxins as Potential Therapeutic Agents
   Ji Qi et al, 2018, Toxins CrossRef
9. Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
   Wenpan Peng et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
10. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway
    Tengyang Ni et al, 2019, Biomedicine & Pharmacotherapy CrossRef